Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention

BACKGROUND: High on-treatment ADP platelet reactivity (HPR) measured by VerifyNow P2Y12 assay (VN) is an established risk factor for ischemic events after percutaneous coronary intervention (PCI). We hypothesized that routine use of VN at time of PCI in clinical practice may affect choice of P2Y12 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mshelbwala, Fakilahyel S, Hugenberg, Daniel W, Kreutz, Rolf P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170549/
https://www.ncbi.nlm.nih.gov/pubmed/32368161
http://dx.doi.org/10.2147/CPAA.S242675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170549/
https://www.ncbi.nlm.nih.gov/pubmed/32368161
http://dx.doi.org/10.2147/CPAA.S242675

Ejemplares similares